[1] ALBAKR R, BARGMAN J. A comparison of hemodialysis and peritoneal dialysis in patients with cardiovascular disease[J]. Cardiol Clin, 2021, 39(3):447-453. [2] WANG Y, GAO L. Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease[J]. Front Pharmacol, 2022, 13: 800950. [3] ZHANG J, PANG Q, WANG S, et al. Associated factors of cardiac valve calcification and its prognostic effects among patients with chronic kidney disease: a systematic review and meta-analysis[J]. Front Cardiovasc Med, 2023, 10: 1120634. [4] MOTURI S, GHOSH-CHOUDHARY S K, FINKEL T. Cardiovascular disease and the biology of aging[J]. J Mol Cell Cardiol, 2022, 167:109-117. [5] 韩年华,王维平,何萍,等.血液透析患者关节超声下尿酸盐沉积与冠状动脉钙化积分的关系[J]. 中华风湿病学杂,2020,24(5):311-316. [6] ZHU J, TANG C, OUYANG H, et al. Prediction of all-cause mortality using an echocardiography-based risk score in hemodialysis patients[J]. Cardiorenal Med, 2021, 11(1): 33-43. [7] BAI J, ZHANG X, ZHANG A, et al. Cardiac valve calcification is associated with mortality in hemodialysis patients: a retrospective cohort study[J]. BMC Nephrol, 2022, 23(1):43. [8] URENA-TORRES P, D'MARCO L, RAGGI P, et al. Valvular heart disease and calcification in CKD: more common than appreciated[J]. Nephrol Dial Transplant, 2020,35(12):2046-2053. [9] ZHANG H, LI G, YU X, et al. Progression of vascular calcification and clinical outcomes in patients receiving maintenance dialysis[J]. JAMA Netw Open, 2023,6(5):e2310909. [10] PLYTZANOPOULOU P, PAPASOTIRIOU M, POLITIS P, et al. Cardiac valve calcification in patients on maintenance dialysis. The role of malnutrition-inflammation syndrome, adiposity and components of sarcopenia. A cross-sectional study[J]. Clin Nutr ESPEN, 2022,52:421-430. [11] WANG L, TANG R, ZHANG Y, et al. PTH-induced EndMT via miR-29a-5p/GSAP/Notch1 pathway contributed to valvular calcification in rats with CKD[J]. Cell Prolif, 2021,54(6):e13018. [12] 邱清艳, 戴闽, 牟英, 等. 美托洛尔联合曲美他嗪对慢性心力衰竭患者血清血管紧张素Ⅱ、血管内皮功能的影响[J]. 实用临床医药杂志, 2021, 25(3): 99-102, 106. [13] BENINCASA G, COSCIONI E, NAPOLI C. Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: novel opportunities for primary prevention[J]. Biochem Pharmacol, 2022, 202: 115108. [14] ALEXANDER Y, OSTO E, SCHMIDT-TRUCKSASS A, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on atherosclerosis and vascular biology, aorta and peripheral vascular diseases, coronary pathophysiology and microcirculation, and thrombosis[J]. Cardiovasc Res, 2021, 117(1): 29-42. [15] HEISS C, RODRIGUEZ-MATEOS A, Bapir M, et al. Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health[J]. Cardiovasc Res, 2023, 119(1): 283-293. |